Cargando…
Sarcosine as a Potential Prostate Cancer Biomarker—A Review
Prostate cancer (CaP) is the most common type of tumour disease in men. Early diagnosis of cancer of the prostate is very important, because the sooner the cancer is detected, the better it is treated. According to that fact, there is great interest in the finding of new markers including amino acid...
Autores principales: | Cernei, Natalia, Heger, Zbynek, Gumulec, Jaromir, Zitka, Ondrej, Masarik, Michal, Babula, Petr, Eckschlager, Tomas, Stiborova, Marie, Kizek, Rene, Adam, Vojtech |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742224/ https://www.ncbi.nlm.nih.gov/pubmed/23880848 http://dx.doi.org/10.3390/ijms140713893 |
Ejemplares similares
-
Paramagnetic Nanoparticles as a Platform for FRET-Based Sarcosine Picomolar Detection
por: Heger, Zbynek, et al.
Publicado: (2015) -
A Novel Insight into the Cardiotoxicity of Antineoplastic Drug Doxorubicin
por: Heger, Zbynek, et al.
Publicado: (2013) -
Influence of Long-Distance Bicycle Riding on Serum/Urinary Biomarkers of Prostate Cancer
por: Heger, Zbynek, et al.
Publicado: (2016) -
Post‐treatment urinary sarcosine as a predictor of recurrent relapses in patients with prostate cancer
por: Gumulec, Jaromir, et al.
Publicado: (2018) -
Prostate tumor attenuation in the nu/nu murine model due to anti-sarcosine antibodies in folate-targeted liposomes
por: Heger, Zbynek, et al.
Publicado: (2016)